Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Director Ernest Mario purchased 100,000 shares of the company’s stock in a transaction dated Tuesday, September 13th. The stock was bought at an average price of $0.79 per share, with a total value of $79,000.00. Following the completion of the transaction, the director now directly owns 530,724 shares of the company’s stock, valued at $419,271.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) opened at 0.7351 on Monday. Tonix Pharmaceuticals Holding Corp. has a 12 month low of $0.73 and a 12 month high of $7.95. The stock’s market capitalization is $19.01 million. The company has a 50-day moving average price of $2.06 and a 200 day moving average price of $2.30.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) last announced its quarterly earnings data on Monday, August 8th. The company reported ($0.50) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.55) by $0.05. Equities analysts predict that Tonix Pharmaceuticals Holding Corp. will post ($1.70) earnings per share for the current year.

A number of research firms have recently issued reports on TNXP. Oppenheimer Holdings Inc. restated a “buy” rating and issued a $13.00 price target (up from $10.00) on shares of Tonix Pharmaceuticals Holding Corp. in a research report on Sunday, May 22nd. Roth Capital lowered Tonix Pharmaceuticals Holding Corp. from a “buy” rating to a “neutral” rating in a research report on Wednesday, September 7th. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $5.00 price target on shares of Tonix Pharmaceuticals Holding Corp. in a research report on Wednesday, August 24th.

A number of large investors have recently made changes to their positions in TNXP. A.R.T. Advisors LLC purchased a new stake in shares of Tonix Pharmaceuticals Holding Corp. during the first quarter worth approximately $117,000. Jacobs Levy Equity Management Inc. purchased a new stake in shares of Tonix Pharmaceuticals Holding Corp. during the first quarter worth approximately $290,000. Sabby Management LLC increased its stake in shares of Tonix Pharmaceuticals Holding Corp. by 52.0% in the second quarter. Sabby Management LLC now owns 585,914 shares of the company’s stock worth $1,166,000 after buying an additional 200,518 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Tonix Pharmaceuticals Holding Corp. by 1.5% in the second quarter. Vanguard Group Inc. now owns 707,065 shares of the company’s stock worth $1,407,000 after buying an additional 10,531 shares during the last quarter. Finally, Opaleye Management Inc. purchased a new stake in shares of Tonix Pharmaceuticals Holding Corp. during the second quarter worth approximately $1,592,000. Hedge funds and other institutional investors own 33.70% of the company’s stock.

Tonix Pharmaceuticals Holding Corp. Company Profile

5 Day Chart for NASDAQ:TNXP

Receive News & Ratings for Tonix Pharmaceuticals Holding Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tonix Pharmaceuticals Holding Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.